News Generic Upadacitinib Approved in China, Marking the Start of JAK Inhibitor Competition DengYueMed, DengYue 28/04/2026
News Belantamab Mafodotin Approved in China for Multiple Myeloma: First-in-Class BCMA ADC Marks New Milestone DengYueMed, DengYue 21/04/2026
News Sevabertinib Approved in China for HER2-Mutant NSCLC: A New Oral Targeted Therapy Option DengYueMed, DengYue 16/04/2026
News NMPA Approves GSK Depemokimab in China for Severe Eosinophilic Asthma with Twice-Yearly Dosing DengYueMed, DengYue 31/03/2026
News ABSK061 Achondroplasia Orphan Drug Designation: Abbisko Therapeutics Advances Targeted Therapy DengYueMed, DengYue 20/03/2026
News 11 New Cancer Drugs Approved: Breakthroughs in Lung Cancer, Breast Cancer and Prostate Cancer Treatment DengYueMed, DengYue 06/03/2026
News NMPA Approved Drugs List – February 2026: 3 Innovative Drugs Approved in China DengYueMed, DengYue 05/03/2026
News What Is Qipani Olaparib Used For? China Approves First Domestic Olaparib Generic, Marking a New Milestone in PARP Inhibitor Access Dengyue 16/02/2026
News Adebrelimab Approval in China: The First Domestic PD-L1 Antibody for Small Cell Lung Cancer Dengyue 10/02/2026
News The Role of Pharmaceutical Wholesalers in 2026: From Channel to Strategic Partner Aligning with Drugmakers’ 6 Priorities Dengyue 23/01/2026
News The Different Forms of Navelbine—From Classic Chemotherapy to a Flexible Multi-Formulation Therapy Dengyue 21/01/2026
News TPIAO Approved for a New Indication: Clinical Progress of Recombinant Human Thrombopoietin in the Treatment of Thrombocytopenia Dengyue 09/01/2026